sulfamethoxazole and trimethoprim
Generic: sulfamethoxazole and trimethoprim
Labeler: avkareDrug Facts
Product Profile
Brand Name
sulfamethoxazole and trimethoprim
Generic Name
sulfamethoxazole and trimethoprim
Labeler
avkare
Dosage Form
TABLET
Routes
Active Ingredients
sulfamethoxazole 400 mg/1, trimethoprim 80 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42291-758
Product ID
42291-758_4a7ee07f-6eea-dd30-e063-6394a90adac9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076899
Listing Expiration
2027-12-31
Marketing Start
2015-08-05
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42291758
Hyphenated Format
42291-758
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sulfamethoxazole and trimethoprim (source: ndc)
Generic Name
sulfamethoxazole and trimethoprim (source: ndc)
Application Number
ANDA076899 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
- 80 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (42291-758-01)
- 500 TABLET in 1 BOTTLE (42291-758-50)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4a7ee07f-6eea-dd30-e063-6394a90adac9", "openfda": {"nui": ["N0000175489", "N0000000191", "N0000187062", "N0000187061", "N0000175504", "M0020790", "N0000185504"], "unii": ["AN164J8Y0X", "JE42381TNV"], "rxcui": ["198334", "198335"], "spl_set_id": ["9f130443-c8e7-9122-8f27-f72f07f3f29e"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Sulfonamide Antimicrobial [EPC]"], "pharm_class_moa": ["Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42291-758-01)", "package_ndc": "42291-758-01", "marketing_start_date": "20150805"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (42291-758-50)", "package_ndc": "42291-758-50", "marketing_start_date": "20161031"}], "brand_name": "Sulfamethoxazole and Trimethoprim", "product_id": "42291-758_4a7ee07f-6eea-dd30-e063-6394a90adac9", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Dihydrofolate Reductase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Sulfonamide Antimicrobial [EPC]", "Sulfonamides [CS]"], "product_ndc": "42291-758", "generic_name": "Sulfamethoxazole and Trimethoprim", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sulfamethoxazole and Trimethoprim", "active_ingredients": [{"name": "SULFAMETHOXAZOLE", "strength": "400 mg/1"}, {"name": "TRIMETHOPRIM", "strength": "80 mg/1"}], "application_number": "ANDA076899", "marketing_category": "ANDA", "marketing_start_date": "20150805", "listing_expiration_date": "20271231"}